Joe Rogan has questioned why certain peptides remain banned in sports, arguing that treatments designed to support injury recovery deserve more research rather than restrictions. During The Joe Rogan Experience #2568 with endurance athlete Ross Edgley, the podcast host discussed BPC-157 and what he believes is a conflict between medical innovation and pharma industry interests.
The conversation turned to BPC-157 while Rogan and Edgley discussed recovery methods and the lengths athletes go to keep their bodies functioning under physical demands.
Edgley noted, “BPC-157 was weird because it was allowed by WADA and then it was banned.”
Rogan was particularly critical of the changing rules surrounding the experimental peptide.
He said, “It should be allowed. All it does is regenerate tissue, or rather help heal tissue.”
He went on to argue that it deserved greater consideration because of reports of its potential benefits for injured athletes.
“There’s zero studies that show there’s any negative effects of BPC-157. And there’s a lot of at least anecdotal evidence first and foremost, that it’s very beneficial for people recovering from injuries. But then there’s other also studies that indicate that it really is helpful for people.”
Rogan’s argument centered on the physical toll of combat sports, where athletes regularly train through pain and accumulate injuries before stepping into the cage. In his view, recovery treatments that could help athletes arrive at competition in better condition warrant serious investigation.
“I think at least peptides that help injuries. Listen, you’re dealing with a sport where your primary goal is to create an injury on your opponent and you’re practicing injuring each other all day long. Like, you’re going to get injuries, and anything that would help these athletes get to the finish line, like get to the cage in reasonable health because they’re always banged up.”
He explained that even elite athletes are rarely completely healthy by the time they finish a training camp.
“Whenever you see even at a world championship level, when you see a guy looks awesome, guarantee that guy’s dealing with some stuff. Guarantee that guy’s got a sore hand, a messed up shoulder, his knee hurts, something’s wrong. There’s no way you get through a 12-week camp with a bunch of trained assassins and you don’t get banged up. You’re getting banged up. And BPC-157 would help those people.”
From there, the discussion shifted toward the financial interests that Rogan believes influence the availability and development of emerging treatments.
“And you know, in this country, there’s this battle between pharma companies that want to patent these peptides and they want to profit off of them. And then there’s also a lot of people who don’t want people taking these therapies because it will cost them money in terms of the amount of orthopedic surgeries they get.”
Rogan suggested that commercial interests could stand in the way of wider access to treatments that might otherwise benefit patients. He continued:
“That’s a real thing and they have influence and there’s, it’s a real problem. And unfortunately, people are willing to sacrifice the greater health and recovery of the entire population for their own personal gain. And that’s dark but accurate.”
Beyond injury recovery, Rogan pointed to other areas where he believes emerging therapies deserve further investigation, including neurological conditions and regenerative medicine.
“If we were really smart, we would be investing an incredible amount of money into studying these things. And there’s not just that, they’re helping people with neurological conditions. They’re helping people recover from like Parkinson syndrome or Parkinson symptoms. You know, they’re doing them intranasally for people that have lung disorders. Like, there’s a lot of really good work that’s being done with stem cells.”
Rogan also acknowledged that not every treatment offered by clinics promoting experimental therapies should be trusted. The growing number of providers advertising cutting-edge procedures makes it important for patients to examine where they are receiving treatment and what evidence supports the claims.
“Does it mean they all are the same and they all work great? No. That’s like, there’s shady places. This is also part of the problem. Like, if you’re traveling to some godforsaken part of the world to go do this therapy because it’s not legal in America, okay, well, you got to be real careful where you’re going.”
Rogan closed out his argument by emphasizing how quickly medical treatments and technologies continue to evolve.
“We’re at the beginning of this stuff. They keep coming out with new innovations and new therapies that are even more effective.”
